Journal of Clinical Oncology Publishes Significant Evidence in Advancing Racial Equity in Cancer Care Through Artera’s Multimodal AI Model
The validation study shows no evidence of algorithmic bias. The development of the model may help mitigate the risk of racial [...]
Artera Unveils Four Presentations at ASTRO 2025 Illustrating its Multimodal Artificial Intelligence (MMAI) Platform’s Scalability, Speed, and Potential to Personalize Treatment Decisions for Multiple Cancers
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predi [...]
Artera Receives U.S. FDA De Novo Marketing Authorization for AI-Digital Pathology Software Revolutionizing Prostate Cancer Care
Novel risk stratification tool advances the frontier of precision oncology by providing access to insights informing critical [...]
U.S. FDA Grants Artera Breakthrough Device Designation for AI-Powered Software Transforming Prostate Cancer Care
Revolutionary designation accelerates access to critical insights guiding on-the-ground treatment decisions in precision onco [...]
Artera Launches Registry Trial to Measure Real-World Impact and Outcomes of its Prostate Test
Data from Artera’s DIRECT-AI registry will assess the test’s impact on cancer care and guide future improvements SAN FRANCISC [...]
Artera Achieves Nationwide Access for its ArteraAI Prostate Test with New York State License
Clinicians and patients throughout New York State can now access personalized, actionable insights to inform prostate cancer [...]
The ArteraAI Prostate Test Enhanced with New Insights for Higher Risk Patients with Localized Prostate Cancer
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predi [...]
Artera Presenting Validation Data at 2025 ASCO Annual Meeting Highlighting How Multimodal AI Platform (MMAI) is Advancing Personalized Cancer Care
Oral presentation selected for Best of ASCO 2025 in recognition of quality, rigor, and impact First validated algorithm to id [...]
Diagnexia and Artera Partner to Bring Groundbreaking AI Prostate Test to the UK
Diagnexia, the UK’s leading provider of AI-powered digital pathology diagnostic services, is thrilled to announce an exclusiv [...]